Department of Surgery, Spaarne Hospital, Hoofddorp, The Netherlands.
J Vasc Surg. 2010 Sep;52(3):760-7. doi: 10.1016/j.jvs.2010.01.049. Epub 2010 Apr 10.
Juxtarenal aortic aneurysms (JAA) account for approximately 15% of abdominal aortic aneurysms. Despite advances in endovascular aneurysm repair, open repair requiring suprarenal aortic cross-clamping is still the treatment of choice for JAA. We performed a systematic review of the literature to determine perioperative mortality and postoperative renal dysfunction after open repair for non-ruptured JAA.
The Medline, Embase, and Cochrane databases were searched to identify all studies reporting non-ruptured JAA repair published between January 1966 and December 2008. Two independent observers selected studies for inclusion, assessed the methodologic quality of the included studies, and performed the data extraction. Study heterogeneity was assessed using forest plots and by calculating the between-study variance. Outcomes were perioperative mortality, postoperative renal dysfunction, and new onset of dialysis. Summary estimates with 95% confidence interval (95% CI) were calculated using a random effects model based on the binomial distribution.
Twenty-one non-randomized cohort studies from 1986 to 2008, reporting on 1256 patients, were included. Heterogeneity between the studies was low. The mean perioperative mortality was 2.9% (95% CI, 1.8 to 4.6). The mean incidence of new onset of dialysis was 3.3% (95% CI, 2.4 to 4.5). Incidence of postoperative renal dysfunction could be derived from 13 studies and ranged from 0% to 39% (median, 18%). In seven studies, cold renal perfusion during suprarenal clamping was performed in order to preserve renal function; however, based upon the included data, definitive conclusions regarding its efficacy could not be drawn.
Open repair of non-ruptured JAA using suprarenal cross-clamping can be performed with acceptable perioperative mortality; however, postoperative deterioration of renal function is a common complication. Preservation of renal function after JAA repair requires further investigation.
肾周主动脉瘤(JAA)约占腹主动脉瘤的 15%。尽管血管内动脉瘤修复术取得了进展,但对于 JAA,仍需采用开放式修复并进行肾上主动脉阻断。我们对文献进行了系统回顾,以确定非破裂性 JAA 开放修复术后围手术期死亡率和术后肾功能障碍。
检索了 Medline、Embase 和 Cochrane 数据库,以确定 1966 年 1 月至 2008 年 12 月期间发表的所有报告非破裂性 JAA 修复的研究。两位独立观察者选择纳入研究,评估纳入研究的方法学质量,并进行数据提取。使用森林图和计算研究间方差来评估研究异质性。结局指标为围手术期死亡率、术后肾功能障碍和新出现的透析。使用基于二项式分布的随机效应模型计算 95%置信区间(95%CI)的汇总估计值。
纳入了 1986 年至 2008 年的 21 项非随机队列研究,共纳入 1256 例患者。研究间的异质性较低。围手术期死亡率平均为 2.9%(95%CI,1.8%至 4.6%)。新出现透析的发生率平均为 3.3%(95%CI,2.4%至 4.5%)。可以从 13 项研究中得出术后肾功能障碍的发生率,范围为 0%至 39%(中位数,18%)。在 7 项研究中,为了保护肾功能,在肾上主动脉阻断期间进行了冷肾灌注;然而,基于纳入的数据,无法得出关于其疗效的明确结论。
采用肾上主动脉阻断的开放式修复非破裂性 JAA 可获得可接受的围手术期死亡率;然而,术后肾功能恶化是常见的并发症。JAA 修复后肾功能的保护需要进一步研究。